MapLight Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- MapLight Therapeutics Inc.
- Former names
- Alvarado Therapeutics, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Redwood City
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MPLT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001770069
- EIN
- 83-2163243
Board of directors
-
Christopher A. Kroeger · Director · Chief Executive OfficerSince 2025
-
George Pavlov · DirectorSince 2025
-
James D. Trenkle · DirectorSince 2025
-
Maria C. Walker · DirectorSince 2025
-
Martin Babler · DirectorSince 2026
-
Nanna Liebach Luneborg · DirectorSince 2025
-
Robert C. Malenka · DirectorSince 2025
-
Timothy John Garnett · DirectorSince 2025
-
Troy Cox · DirectorSince 2026
Chief executives
Christopher A. Kroeger
· Chief Executive Officer
Since October 2025
Director election results
Annual meeting of June 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
89.8%
-
97.8%
-
99.9%
Board connections
3 of this board's directors also sit on 7 other boards.
- via Martin Babler
- via Maria C. Walker
- via Martin Babler
- via Martin Babler
- via Troy Cox
- via Troy Cox
- via Troy Cox
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $174,929,331
- 12 purchases by 5 insiders
- Sold, last 12 months
- $29,175,788
- 139 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 16, 2026 | Hanson Kristopher Officer (General Counsel) | Open-market sale | −16,509 | $11.67 | $192,660 |
| Aug 17, 2026 | Foff Erin Pennock Officer (Chief Medical Officer) | Grant or award | +13,360 | — | — |
| Aug 17, 2026 | GILLIS JONATHAN Officer (CAO and Interim CFO) | Grant or award | +6,020 | — | — |
| Aug 17, 2026 | Hanson Kristopher Officer (General Counsel) | Grant or award | +7,730 | — | — |
| Aug 17, 2026 | Kreitzer Anatol Officer (Chief Discovery Officer) | Grant or award | +6,020 | — | — |
| Aug 17, 2026 | Christopher A. Kroeger Director, Officer (Chief Executive Officer) | Grant or award | +23,145 | — | — |
| Aug 17, 2026 | Lillie James Woodruff Officer (Chief Scientific Officer) | Grant or award | +7,730 | — | — |
| Aug 17, 2026 | GILLIS JONATHAN Officer (CAO and Interim CFO) | Grant or award | +2,222 | — | — |
| Aug 14, 2026 | Catalyst4, Inc. 10% owner | Open-market purchase | +4,400,000 | $11.38 | $50,072,000 |
| Aug 3, 2026 | Lillie James Woodruff Officer (Chief Scientific Officer) | Open-market sale | −22,082 | $12.54 | $276,908 |
| Jul 30, 2026 | Catalyst4, Inc. 10% owner | Open-market purchase | +1,000,000 | $13.00 | $13,000,000 |
| Jul 29, 2026 | Catalyst4, Inc. 10% owner | Open-market purchase | +3,000 | $12.63 | $37,890 |
| Jul 28, 2026 | Troy Cox Director | Open-market purchase | +15,620 | $9.52 | $148,702 |
| Jul 28, 2026 | Catalyst4, Inc. 10% owner | Open-market purchase | +141,088 | $10.74 | $1,515,511 |
| Jul 28, 2026 | Catalyst4, Inc. 10% owner | Open-market purchase | +65,137 | $11.69 | $761,393 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.